Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03997253 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management

Study acronym: BIOSUPORT
StatusRecruiting
PhaseNot applicable
Started2020-12-21
View on ClinicalTrials.gov ↗

Amendment history

2026-06-25
Study Status v7
Primary completion date2025-02→2027-06
Completion date2025-11→2027-06
2024-03-28
Study Status, Sponsor/Collaborators, Study Description, Study Design, Arms and Interventions, Eligibility, Contacts/Locations v6
Primary completion date2023-02→2025-02
Completion date2024-11→2025-11
Enrollment target300→430
Study sites3→4
Eligibility criteria+8 characters
[...] , liver or heart transplant followed by at least one of the UHFFHU SUPORT centers (Tours, Poitiers, Limoges, Rennes) having given informed consent to participate in the cohort [...]
Collaborators+41 characters
University Hospital Federation FHU SUPORT
2021-10-08
Study Status, Contacts/Locations v5
Study sites1→3
2021-09-30
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v4
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2020-05→confirmed 2020-12-21
Study sites0→1
2020-04-07
Study Status v3
Start date2020-02→2020-05
Show 2 earlier versions
2020-01-02
Study Status v2
Primary completion date2022-11→2023-02
Completion date2023-02→2024-11
Start date2019-11→2020-02
2019-10-04
Study Status v1
Primary completion date2022-09→2022-11
Completion date2022-12→2023-02
Start date2019-09→2019-11
2019-06-24
Original filing
Increased indications for transplantation continue to worsen the shortage of organs and need the extension of graft sampling criteria and the search for new potential sources of organs. Despite undeniable success in the short term, due to major advances in surgery, medicine and research, transplant recipients continue to face the risk of chronic rejection and long-term complications. The University Hospital Federation "FHU SUPORT" was created to optimize the chances of success of the organ transplant and improve the quality of life of the transplanted patient. FHU SUPORT 's ambition is based on a translational strategy that presents two priority areas: Axis 1: Optimization, evaluation, conditioning of the donor, graft, recipient Axis 2: Personalized follow-up of the transplanted patient in the short and long term Identifying factors for long-term graft and patient survival through translational research from a common cohort and biological collection will predict transplant rejection, prolong graft function, or improve the patient's care.
Trial Details
NCT Number NCT03997253
Lead Sponsor University Hospital, Limoges
Collaborators: University Hospital Federation FHU SUPORT
Conditions Organ Transplantation
Enrollment 430 participants
Start Date 2020-12-21
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-29